Mosliciguat is under clinical development by Bayer and currently in Phase I for Kidney Disease (Nephropathy). According to GlobalData, Phase I drugs for Kidney Disease (Nephropathy) have a 71% phase ...

Treprostinil is under clinical development by United Therapeutics and currently in Phase III for Idiopathic Pulmonary Fibrosis.

Increasing average concentrations of sotatercept improved 6-minute walk distance, pulmonary vascular resistance, and levels of NT-proBNP.

INR:8451. portugal league table Jiyao Holdings was fined RMB 1.3 million by the China Securities Regulatory Commission for suspected illegal information dis ...

INR:6834. ronaldinho age Wuhan will negotiate prices for 30 key monitored drugs, with companies' quotations to drop by at least 30% Zhengda Tianqing's first generi ...

how do i login to bet365 Fosun Pharma's Phase I clinical trial of novel coronavirus mRNA vaccine approved Domestic drugs are rising in the pulmonary arterial hypertension market, and original research ...

INR:4979. kalyan final number today Bristol-Myers Squibb's Abatacept Injection is approved for marketing by the National Medical Products Administration ...

INR:4330. 2019 cricket world cup Zhengda Tianqing's first generic version of pulmonary arterial hypertension drug "Macitentan Tablets" is about to be appro ...

INR:1918. ghaziabad record satta Merck's Keytruda combination therapy reaches primary endpoint in Phase 3 clinical trial In-depth review: FDA approved 53 i ...

INR:5148. acl injury recovery time football Two pulmonary arterial hypertension drugs are simultaneously planned to be included in the priority ...

Blackjack 41 Ruby Zhengda Tianqing's first generic version of pulmonary arterial hypertension drug "Macitentan Tablets" is about to be approved Clinic ...

The top articles about pulmonary arterial hypertension (PAH) in 2024 included FDA approvals, the effect of salt substitutes ...